MAR vs RLAY · P/E 32, rev $26.19B vs rev $10.0M
Marriott International Inc (MAR) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the MAR and RLAY stock pages for the full models.
Not investment advice.